Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active agents. Its structure supports the creation of compounds with potential antidepressant, anxiolytic, or antipsychotic activity. The trifluoromethyl group enhances metabolic stability and membrane permeability, making it valuable in medicinal chemistry for optimizing drug candidates. Commonly employed in research settings for designing novel bioactive molecules.